vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and KKR Real Estate Finance Trust Inc. (KREF). Click either name above to swap in a different company.
KKR Real Estate Finance Trust Inc. is the larger business by last-quarter revenue ($25.8M vs $13.8M, roughly 1.9× Gossamer Bio, Inc.). KKR Real Estate Finance Trust Inc. runs the higher net margin — -101.7% vs -342.3%, a 240.6% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -26.6%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.
GOSS vs KREF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $25.8M |
| Net Profit | $-47.2M | $-26.2M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | -105.1% |
| Net Margin | -342.3% | -101.7% |
| Revenue YoY | 47.1% | -26.6% |
| Net Profit YoY | -43.0% | -229.6% |
| EPS (diluted) | $-0.21 | $-0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $25.8M | ||
| Q3 25 | $13.3M | $25.3M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $31.3M | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | — | $37.0M | ||
| Q2 24 | $95.8M | $40.4M | ||
| Q1 24 | $0 | $39.1M |
| Q4 25 | $-47.2M | $-26.2M | ||
| Q3 25 | $-48.2M | $13.8M | ||
| Q2 25 | — | $-29.7M | ||
| Q1 25 | — | $-4.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | — | $-7.4M | ||
| Q2 24 | $49.2M | $25.8M | ||
| Q1 24 | $-41.9M | $-3.1M |
| Q4 25 | -333.6% | -105.1% | ||
| Q3 25 | -369.4% | 50.4% | ||
| Q2 25 | — | -101.3% | ||
| Q1 25 | — | -18.3% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | — | -19.6% | ||
| Q2 24 | 54.3% | 63.3% | ||
| Q1 24 | — | -8.7% |
| Q4 25 | -342.3% | -101.7% | ||
| Q3 25 | -362.7% | 54.4% | ||
| Q2 25 | — | -98.5% | ||
| Q1 25 | — | -15.5% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | — | -20.0% | ||
| Q2 24 | 51.4% | 63.9% | ||
| Q1 24 | — | -7.9% |
| Q4 25 | $-0.21 | $-0.49 | ||
| Q3 25 | $-0.21 | $0.12 | ||
| Q2 25 | — | $-0.53 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $-0.19 | ||
| Q2 24 | $0.22 | $0.29 | ||
| Q1 24 | $-0.19 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $84.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $1.2B |
| Total Assets | $172.2M | $6.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $84.6M | ||
| Q3 25 | $180.2M | $204.1M | ||
| Q2 25 | — | $107.7M | ||
| Q1 25 | — | $106.4M | ||
| Q4 24 | — | $104.9M | ||
| Q3 24 | — | $108.8M | ||
| Q2 24 | $354.5M | $107.2M | ||
| Q1 24 | $244.4M | $106.5M |
| Q4 25 | $-122.8M | $1.2B | ||
| Q3 25 | $-82.3M | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $81.5M | $1.4B | ||
| Q1 24 | $26.7M | $1.4B |
| Q4 25 | $172.2M | $6.5B | ||
| Q3 25 | $208.8M | $6.5B | ||
| Q2 25 | — | $6.8B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.8B | ||
| Q2 24 | $373.4M | $7.1B | ||
| Q1 24 | $259.4M | $7.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $72.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $72.3M | ||
| Q3 25 | $-36.2M | $18.5M | ||
| Q2 25 | — | $21.1M | ||
| Q1 25 | — | $15.9M | ||
| Q4 24 | — | $132.6M | ||
| Q3 24 | — | $49.1M | ||
| Q2 24 | $116.3M | $30.6M | ||
| Q1 24 | $-52.3M | $34.5M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | 1.19× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
